This correlated with an increased expression of CD107a, which has been associated in NK cells with an enhanced cytokine secretion and improved lysis of target cells [7,69], although the percentage of NK cells expressing activation markers such as CD107a has been described to be lower in individuals with COVID-19 in comparison to healthy controls [70]. The gene discussed is LAMP1; the disease is COVID-19.